newsfilter
← Latest News
GlobeNewswire·

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

Completed cohort 1 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancers in February 2025 and plan to initiate backfill cohorts in the second half of 2025Cash of approximately $68.6 million expected to fund